[ad_1] NEW YORK, Nov. 20, 2025 /PRNewswire/ — Purcell & Lefkowitz LLP announces that it is investigating Zenas BioPharma, Inc. (NASDAQ: ZBIO) on behalf of the company’s shareholders. The investigation seeks to determine whether Zenas BioPharma’s directors […]
Tag: Purcell & Lefkowitz LLP
Purcell & Lefkowitz LLP Announces Shareholder Investigation of Palisade Bio, Inc. (NASDAQ: PALI)
[ad_1] NEW YORK, Oct. 20, 2025 /PRNewswire/ — Purcell & Lefkowitz LLP announces that it is investigating Palisade Bio, Inc. (NASDAQ: PALI) on behalf of the company’s shareholders. The investigation seeks to determine whether Palisade […]
Purcell & Lefkowitz LLP Announces Shareholder Investigation of Skillsoft Corp. (NYSE: SKIL)
[ad_1] NEW YORK, Oct. 9, 2024 /PRNewswire/ — Purcell & Lefkowitz LLP announces that it is investigating Skillsoft Corp. (NYSE: SKIL) on behalf of the company’s shareholders. The investigation seeks to determine whether Skillsoft’s directors breached […]
Purcell & Lefkowitz LLP Announces Shareholder Investigation of Vaxcyte, Inc. (NASDAQ: PCVX)
[ad_1] NEW YORK, Aug. 26, 2024 /PRNewswire/ — Purcell & Lefkowitz LLP announces that it is investigating Vaxcyte, Inc. (NASDAQ: PCVX) on behalf of the company’s shareholders. The investigation seeks to determine whether Vaxcyte’s directors […]
Purcell & Lefkowitz LLP Announces Shareholder Investigation of Verve Therapeutics, Inc. (NASDAQ: VERV)
[ad_1] NEW YORK, Aug. 8, 2024 /PRNewswire/ — Purcell & Lefkowitz LLP announces that it is investigating Verve Therapeutics, Inc. (NASDAQ: VERV) on behalf of the company’s shareholders. The investigation seeks to determine whether Verve […]













